Loading…

Medtronic plc announced it has entered into definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch tubeless insulin delivery device.
“Our goal is to simplify diabetes management and deliver the well-established benefits of automated insulin delivery to our customers in the ways they want and need.”news.medtronic.com
Summarized from public sources; check the original articles before acting on it.